These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 9753220)
1. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing. Arakawa T; Kobayashi K; Yoshikawa T; Tarnawski A Dig Dis Sci; 1998 Sep; 43(9 Suppl):5S-13S. PubMed ID: 9753220 [TBL] [Abstract][Full Text] [Related]
2. Rebamipide treatment activates epidermal growth factor and its receptor expression in normal and ulcerated gastric mucosa in rats: one mechanism for its ulcer healing action? Tarnawski A; Arakawa T; Kobayashi K Dig Dis Sci; 1998 Sep; 43(9 Suppl):90S-98S. PubMed ID: 9753233 [TBL] [Abstract][Full Text] [Related]
3. Rebamipide reduces recurrence of experimental gastric ulcers: role of free radicals and neutrophils. Sakurai K; Osaka T; Yamasaki K Dig Dis Sci; 2005 Oct; 50 Suppl 1():S90-6. PubMed ID: 16184427 [TBL] [Abstract][Full Text] [Related]
4. Effect of rebamipide on mucus secretion by endogenous prostaglandin-independent mechanism in rat gastric mucosa. Ishihara K; Komuro Y; Nishiyama N; Yamasaki K; Hotta K Arzneimittelforschung; 1992 Dec; 42(12):1462-6. PubMed ID: 1337697 [TBL] [Abstract][Full Text] [Related]
6. Effect of rebamipide on gastric ulcer healing caused by Helicobacter pylori and/or NSAIDs or non NSAIDs-non H. pylori. Thong-Ngam D; Chayanupatkul M; Klaikeaw N; Rerknimitr R; Mahachai V J Med Assoc Thai; 2009 Sep; 92(9):1207-12. PubMed ID: 19772181 [TBL] [Abstract][Full Text] [Related]
7. Rebamipide induces the gastric mucosal protective factor, cyclooxygenase-2, via activation of 5'-AMP-activated protein kinase. Lee S; Jeong S; Kim W; Kim D; Yang Y; Yoon JH; Kim BJ; Min DS; Jung Y Biochem Biophys Res Commun; 2017 Jan; 483(1):449-455. PubMed ID: 28011266 [TBL] [Abstract][Full Text] [Related]
8. 15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications. Arakawa T; Higuchi K; Fujiwara Y; Watanabe T; Tominaga K; Sasaki E; Oshitani N; Yoshikawa T; Tarnawski AS Dig Dis Sci; 2005 Oct; 50 Suppl 1():S3-S11. PubMed ID: 16184418 [TBL] [Abstract][Full Text] [Related]
9. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent. Sun WH; Tsuji S; Tsujii M; Gunawan ES; Kawai N; Kimura A; Kakiuchi Y; Yasumaru M; Iijima H; Okuda Y; Sasaki Y; Hori M; Kawano S J Pharmacol Exp Ther; 2000 Nov; 295(2):447-52. PubMed ID: 11046075 [TBL] [Abstract][Full Text] [Related]
10. In vitro studies indicating antioxidative properties of rebamipide. Iinuma S; Naito Y; Yoshikawa T; Takahashi S; Takemura T; Yoshida N; Kondo M Dig Dis Sci; 1998 Sep; 43(9 Suppl):35S-39S. PubMed ID: 9753224 [TBL] [Abstract][Full Text] [Related]
11. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants. Suzuki M; Miura S; Mori M; Kai A; Suzuki H; Fukumura D; Suematsu M; Tsuchiya M Gut; 1994 Oct; 35(10):1375-8. PubMed ID: 7959190 [TBL] [Abstract][Full Text] [Related]
12. Rebamipide activates genes encoding angiogenic growth factors and Cox2 and stimulates angiogenesis: a key to its ulcer healing action? Tarnawski AS; Chai J; Pai R; Chiou SK Dig Dis Sci; 2004 Feb; 49(2):202-9. PubMed ID: 15104358 [TBL] [Abstract][Full Text] [Related]
13. Rebamipide prevents delay of acetic acid-induced gastric ulcer healing caused by Helicobacter pylori infection in Mongolian gerbils. Watanabe T; Higuchi K; Hamaguchi M; Tanigawa T; Wada R; Tominaga K; Fujiwara Y; Arakawa T Dig Dis Sci; 2002 Jul; 47(7):1582-9. PubMed ID: 12141820 [TBL] [Abstract][Full Text] [Related]
14. Effect of rebamipide on gastric bleeding and ulcerogenic responses induced by aspirin plus clopidogrel under stimulation of acid secretion in rats. Takeuchi K; Takayama S; Hashimoto E; Itayama M; Amagase K; Izuhara C J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():37-46. PubMed ID: 25521732 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic effect of rebamipide against the irritative and healing impairment actions of alendronate in rat stomachs. Aihara E; Hayashi S; Amagase K; Kato S; Takeuchi K Inflammopharmacology; 2007 Oct; 15(5):196-202. PubMed ID: 17943251 [TBL] [Abstract][Full Text] [Related]
16. Effect of rebamipide on H. pylori-associated gastric mucosal injury in Mongolian gerbils. Suzuki H; Mori M; Kai A; Suzuki M; Suematsu M; Miura S; Ishii H Dig Dis Sci; 1998 Sep; 43(9 Suppl):181S-187S. PubMed ID: 9753247 [TBL] [Abstract][Full Text] [Related]
17. [The cytoprotective drug rebamipide in therapy for inflammatory and erosive-ulcerative lesions of the gastrointestinal tract]. Yakovenko EP; Agafonova NA; Ivanov AN; Yakovenko AV; Aldiyarova MA; Volosheinikova TV; Grigoryeva YV; Soluyanova IP Ter Arkh; 2016; 88(4):88-92. PubMed ID: 27070169 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of rebamipide on the neutrophil adherence stimulated by conditioned media from Helicobacter pylori-infected gastric epithelial cells. Kim CD; Kim HH; Hong KW J Pharmacol Exp Ther; 1999 Jan; 288(1):133-8. PubMed ID: 9862763 [TBL] [Abstract][Full Text] [Related]
19. Rebamipide induces dendritic cell recruitment to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-exposed rat gastric mucosa based on IL-1β upregulation. Yamamichi N; Oka M; Inada K; Konno-Shimizu M; Kageyama-Yahara N; Tamai H; Kato J; Fujishiro M; Kodashima S; Niimi K; Ono S; Tsutsumi Y; Ichinose M; Koike K Biochem Biophys Res Commun; 2012 Jul; 424(1):124-9. PubMed ID: 22732404 [TBL] [Abstract][Full Text] [Related]